Ceruloplasmin Testing in Wilson's Disease
Serum ceruloplasmin should be routinely measured in all patients aged 3-55 years with unexplained liver disease, neurological symptoms, or psychiatric abnormalities, but a normal ceruloplasmin level does NOT exclude Wilson's disease and requires additional diagnostic testing. 1, 2
Critical Diagnostic Limitations
The ceruloplasmin test has significant limitations that every clinician must understand:
- 15-36% of children with Wilson's disease have ceruloplasmin in the normal range 3
- Up to 50% of patients with hepatic Wilson's disease may have low-normal ceruloplasmin levels 3
- In one series, 22% of Wilson's disease patients (12 of 55) had normal ceruloplasmin AND no Kayser-Fleischer rings 3
- The positive predictive value of low ceruloplasmin alone is only 5.9-6%, meaning most patients with low ceruloplasmin do NOT have Wilson's disease 2, 3, 4
When to Order Ceruloplasmin
Order ceruloplasmin testing in these specific clinical scenarios:
Hepatic Presentations
- Unexplained elevated aminotransferases at any age 3-55 years 2, 3
- Isolated hepatomegaly or fatty liver of unknown cause 3
- Cirrhosis without clear etiology 3
- Fulminant hepatic failure 3, 5
- Autoimmune hepatitis failing standard immunosuppressive therapy 3
Neurological Presentations
- Tremor, dystonia, dysarthria, or drooling 2, 3
- Movement disorders or coordination problems 3
- Deteriorating handwriting (micrographia) 2
- Behavioral deterioration or declining school performance 2
Psychiatric Presentations
- Depression, anxiety, or personality changes with ANY liver abnormality 2, 3
- Frank psychosis in young adults 2
Other Presentations
- Unexplained Coombs-negative hemolytic anemia with liver dysfunction 3, 5
- First-degree relatives of confirmed Wilson's disease patients 3
Interpreting Ceruloplasmin Results
Extremely Low Levels (<50 mg/L or <5 mg/dL)
Modestly Low Levels (<200 mg/L or <20 mg/dL but >50 mg/L)
- Suggests further evaluation is necessary but is NOT diagnostic 1
- Approximately 20% of heterozygous carriers (who do NOT have disease) have decreased ceruloplasmin 1, 3
Normal Levels (≥200 mg/L or ≥20 mg/dL)
- Does NOT exclude Wilson's disease 1, 3
- Must proceed with additional diagnostic testing if clinical suspicion remains 3
Essential Follow-Up Testing When Ceruloplasmin is Abnormal OR Clinical Suspicion Remains High
Proceed with this diagnostic algorithm:
24-hour urinary copper excretion (using copper-free glassware)
- Values >100 μg/24 hours (>1.6 μmol/24 hours) indicate Wilson's disease 3
Calculate non-ceruloplasmin-bound (free) copper
- Values >25 μg/dL (250 μg/L) strongly suggest Wilson's disease 3
Slit-lamp examination by experienced ophthalmologist
Consider genetic testing for ATP7B mutations
- Two pathogenic mutations confirm diagnosis 3
Hepatic copper concentration if liver biopsy performed
4 μmol/g dry weight (>250 μg/g) provides best biochemical evidence 3
Critical Pitfalls to Avoid
False Elevation of Ceruloplasmin
- Ceruloplasmin is an acute phase reactant and can be falsely elevated by 2, 3:
- Acute inflammation or infection
- Pregnancy
- Estrogen supplementation or oral contraceptives
Assay Limitations
- Immunologic assays may overestimate ceruloplasmin because they measure both apo- and holoceruloplasmin (only holoceruloplasmin contains copper) 2, 3
- Enzymatic assays measuring oxidase activity are more specific than immunologic assays 6
Age-Related Variations
- Ceruloplasmin is physiologically very low in infancy (up to 6 months), peaks above adult levels in early childhood, then normalizes 2, 3
- Age alone should NEVER exclude Wilson's disease from consideration 2, 3
Other Causes of Low Ceruloplasmin
Low ceruloplasmin occurs in conditions OTHER than Wilson's disease 2, 3:
- Severe protein loss (nephrotic syndrome, protein-losing enteropathy)
- End-stage liver disease of any etiology
- Copper deficiency (parenteral nutrition without trace elements)
- Menkes disease (X-linked copper transport disorder)
- Aceruloplasminemia (presents with hemosiderosis, not copper accumulation)
Impact on Morbidity and Mortality
Early diagnosis through appropriate ceruloplasmin testing and comprehensive evaluation is critical because:
- Wilson's disease is fatal if untreated but has excellent outcomes with early copper chelation therapy 7
- Delayed diagnosis leads to irreversible neurological damage and end-stage liver disease 5, 7
- Only 65% of patients presenting with liver disease are diagnosed by typical findings (low ceruloplasmin + Kayser-Fleischer rings), compared to 90% with neurological disease 5